Bioenergy Life Science, Inc.   Report issue

For profit
Founded: Andover MN United States (2012)
Status: Left NME R&D (2019)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Bioenergy Life Science, Inc.

Active Ingredients

Drugs in Other Trials (2)

d-ribose (3 trials)

glucose monohydrate (2 trials)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 3
  • # of Trial APIs: 2